Lucija Božičević, Karolina Jagiello, Anita Sosnowska, Maciej Stepnik, Maria Dusinska, Iseult Lynch, Nikolina Peranić, Ivona Capjak, Valérie Fessard, Mihaela R Cimpan, Arno C Gutleb, Elise Runden Pran, Tomasz Puzyn, Ivana Vinković Vrček
{"title":"Sex and Gender Dimensions in Hazard and Risk Assessment of Engineered Nanomaterials.","authors":"Lucija Božičević, Karolina Jagiello, Anita Sosnowska, Maciej Stepnik, Maria Dusinska, Iseult Lynch, Nikolina Peranić, Ivona Capjak, Valérie Fessard, Mihaela R Cimpan, Arno C Gutleb, Elise Runden Pran, Tomasz Puzyn, Ivana Vinković Vrček","doi":"10.1002/wnan.70034","DOIUrl":null,"url":null,"abstract":"<p><p>The knowledge on hazards and risks connected to human exposure to engineered nanomaterials (ENMs) is still very limited, despite several decades of research and regulatory efforts at the international level. In particular, sex/gender-related responses to such exposure have not been clearly articulated so far in any of the existing guidance documents or regulatory relevant opinions provided to the parties involved in the risk assessment and risk management of ENMs. We aimed to demonstrate the relevance of the sex/gender dimension for the characterization of the risks and hazards associated with ENMs by analyzing existing scientific data on sex-related differences in response to ENMs exposure. This was achieved by performing an extensive review of in vivo mammalian toxicity studies published in PubMed and Web of Science databases. Further analysis was performed only for data reported in publications that satisfied scientific quality criteria assessed using the GUIDEnano approach. Finally, we demonstrated the importance of the sex/gender dimension for safety testing of ENMs in the future and provided recommendations on how to include the sex/gender dimension in toxicity testing of ENMs to ensure precise, transparent, and reliable conclusions in the process of hazard and risk assessments. This article is categorized under: Toxicology and Regulatory Issues in Nanomedicine > Toxicology of Nanomaterials Toxicology and Regulatory Issues in Nanomedicine > Regulatory and Policy Issues in Nanomedicine.</p>","PeriodicalId":94267,"journal":{"name":"Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology","volume":"17 5","pages":"e70034"},"PeriodicalIF":8.2000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12444842/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/wnan.70034","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The knowledge on hazards and risks connected to human exposure to engineered nanomaterials (ENMs) is still very limited, despite several decades of research and regulatory efforts at the international level. In particular, sex/gender-related responses to such exposure have not been clearly articulated so far in any of the existing guidance documents or regulatory relevant opinions provided to the parties involved in the risk assessment and risk management of ENMs. We aimed to demonstrate the relevance of the sex/gender dimension for the characterization of the risks and hazards associated with ENMs by analyzing existing scientific data on sex-related differences in response to ENMs exposure. This was achieved by performing an extensive review of in vivo mammalian toxicity studies published in PubMed and Web of Science databases. Further analysis was performed only for data reported in publications that satisfied scientific quality criteria assessed using the GUIDEnano approach. Finally, we demonstrated the importance of the sex/gender dimension for safety testing of ENMs in the future and provided recommendations on how to include the sex/gender dimension in toxicity testing of ENMs to ensure precise, transparent, and reliable conclusions in the process of hazard and risk assessments. This article is categorized under: Toxicology and Regulatory Issues in Nanomedicine > Toxicology of Nanomaterials Toxicology and Regulatory Issues in Nanomedicine > Regulatory and Policy Issues in Nanomedicine.
尽管在国际层面进行了几十年的研究和监管努力,但关于人类接触工程纳米材料(enm)的危害和风险的知识仍然非常有限。特别是,迄今为止,在向参与环境管理产品风险评估和风险管理的各方提供的任何现有指导文件或监管相关意见中,都没有明确阐明对这种接触的与性别/性别有关的反应。我们的目的是通过分析现有的科学数据来证明性别/性别维度与enm暴露相关的风险和危害的相关性。这是通过对发表在PubMed和Web of Science数据库上的哺乳动物体内毒性研究进行广泛审查而实现的。仅对出版物中报告的满足GUIDEnano方法评估的科学质量标准的数据进行进一步分析。最后,我们论证了性别/性别维度在未来农药安全检测中的重要性,并就如何在农药毒性检测中纳入性别/性别维度提出了建议,以确保在危害和风险评估过程中得出准确、透明和可靠的结论。本文分类为:纳米医学的毒理学和监管问题bbb纳米材料毒理学和监管问题bbb纳米医学的监管和政策问题。